We demonstrated for the first time that manipulating TGF-β/PGE2 balance combined with hypo-RT was beneficial in re-establishing DC maturation, homing to LNs, and cross-priming of T cells, which consequently could magnify the anti-tumor immune response. This evidence concerns the gene TGFB1 and neoplasm.